Capricor Therap Cmn (NASDAQ:CAPR)’s share price plunged -8.29% or -0.17 to reach at $1.88 during previous trading session. A total of 853117 shares exchanged hands, whereas the company’s average trading volume stands at 2.2 Million shares. Capricor Therap Cmn (NASDAQ:CAPR) has a market capitalization of $48.33 Million and most recently 25.71 Million outstanding shares have been calculated.
According to sentiments of 1 analysts the mean estimates of short term price target for the company’s stock is marked at $6.5. The most optimistic analyst sees the stock reaching $6.5 while the most conventional predicts the target price at $6.5.
In terms of Buy/Sell recommendations, 1 analysts have a consensus rating of 1 on the shares of Capricor Therap Cmn (NASDAQ:CAPR). Out of rating recommendations 0 have given the stock a Buy while 1 recommend the stock as Outperform. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.
Capricor Therap Cmn (NASDAQ:CAPR)’s distance from 20 day simple moving average is -0.1568 along with distance from 50 day simple moving average of 2.31 whereas its distance from 200 day simple moving average is 1.47. Capricor Therap Cmn (NASDAQ:CAPR)’s price distance from 52-week high is -55.76 and from 52-week low is 196.53. The stock hit its 52-week high price on 10/02/17, and 52-week low price on 06/23/17. The stock’s 52-week price fluctuated within the range of $4.25 – $0.63.
Capricor Therap Cmn (NASDAQ:CAPR)’s shares slipped -10.48% in the past week and plunged -24.19% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 127.88% while its year to date performance is at -29.32%.
While taking a glance at financials, we can look at a number of key indicators. Capricor Therap Cmn (NASDAQ:CAPR) has a Return on Assets (ROA) of -101.8. The company currently has a Return on Equity (ROE) of 410.7 and a Return on Investment (ROI) of -142.1. Average true range (ATR-14) of the company sets at 0.26, along with its weekly and monthly volatility of 11.09% and 12.55% respectively. Relative strength index (RSI-14) for Capricor Therap Cmn (NASDAQ:CAPR) is at 35.34. Beta value of the stock stands at -2.78.
The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 0.8 along with current ratio for most recent quarter of 0.8. Total debt to equity ratio of Capricor Therap Cmn (NASDAQ:CAPR) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0.
Shares of Photronics Inc (NASDAQ:PLAB) plunged -7.66% or -0.8 to reach at $9.65 during previous trading session. Photronics Inc (NASDAQ:PLAB) has a market capitalization of $661.27 Million and most recently 68.53 Million outstanding shares have been calculated. A total of 760110 shares exchanged hands, whereas the company’s average trading volume stands at 917.01 Million shares.